Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Split ends antagonizes the Notch and potentiates the EGFR signaling pathways during Drosophila eye development.

Mechanisms of development | 2007

The Notch and Epidermal Growth Factor Receptor (EGFR) signaling pathways interact cooperatively and antagonistically to regulate many aspects of Drosophila development, including the eye. How output from these two signaling networks is fine-tuned to achieve the precise balance needed for specific inductive interactions and patterning events remains an open and important question. Previously, we reported that the gene split ends (spen) functions within or parallel to the EGFR pathway during midline glial cell development in the embryonic central nervous system. Here, we report that the cellular defects caused by loss of spen function in the developing eye imaginal disc place spen as both an antagonist of the Notch pathway and a positive contributor to EGFR signaling during retinal cell differentiation. Specifically, loss of spen results in broadened expression of Scabrous, ectopic activation of Notch signaling, and a corresponding reduction in Atonal expression at the morphogenetic furrow. Consistent with Spen's role in antagonizing Notch signaling, reduction of spen levels is sufficient to suppress Notch-dependent phenotypes. At least in part due to loss of Spen-dependent down-regulation of Notch signaling, loss of spen also dampens EGFR signaling as evidenced by reduced activity of MAP kinase (MAPK). This reduced MAPK activity in turn leads to a failure to limit expression of the EGFR pathway antagonist and the ETS-domain transcriptional repressor Yan and to a corresponding loss of cell fate specification in spen mutant ommatidia. We propose that Spen plays a role in modulating output from the Notch and EGFR pathways to ensure appropriate patterning during eye development.

Pubmed ID: 17588724 RIS Download

Associated grants

  • Agency: NEI NIH HHS, United States
    Id: R01 EY012549-08
  • Agency: NEI NIH HHS, United States
    Id: R01 EY012549
  • Agency: NEI NIH HHS, United States
    Id: R01 EY012549-03
  • Agency: NEI NIH HHS, United States
    Id: R01 EY12549
  • Agency: NEI NIH HHS, United States
    Id: R01 EY012549-06
  • Agency: NEI NIH HHS, United States
    Id: R01 EY012549-04
  • Agency: NEI NIH HHS, United States
    Id: R01 EY012549-01
  • Agency: NEI NIH HHS, United States
    Id: R01 EY012549-05
  • Agency: NEI NIH HHS, United States
    Id: R01 EY012549-07
  • Agency: NEI NIH HHS, United States
    Id: R01 EY012549-05S1
  • Agency: NEI NIH HHS, United States
    Id: R01 EY012549-09
  • Agency: NEI NIH HHS, United States
    Id: R01 EY012549-02

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


DSHB (tool)

RRID:SCR_013527

An antibody supplier which banks and distributes hybridomas and monoclonal antibodies for use in research. The bank includes antibodies against targets such as GFP, transcription factors, stem cells, and human.

View all literature mentions

Rat-Elav-7E8A10 anti-elav antibody, deposited by Rubin, G.M. HHMI / Janelia Farm Research (antibody)

RRID:AB_528218

This monoclonal targets elav Drosophila protein; embryonic lethal abnormal vision

View all literature mentions